• FEI Logo

    FEI Reports Third Quarter Results

      FEI Company (Nasdaq:FEIC) reported results for third quarter of 2014. Revenue of $227.8 million was up 4.2% compared to $218.5 million in the third quarter of 2013 and down 3.9% compared to $237.0 million in the second quarter of 2014. Net bookings in the third quarter were $250.1 million with a book-to-bill ratio of […]

  • Pacific Biosciences Logo

    Sales at Pacific Biosciences Up 178% in Q3

      Pacific Biosciences of California, Inc. (Nasdaq:PACB) today reported a 178% increase in revenue to $20.6 million for the third quarter ended September 30, 2014, compared to $7.4 million for the third quarter of 2013. Third quarter 2014 revenue included the achievement of the $10.0 million milestone related to Roche along with the $1.7 million quarterly amortization from the upfront Roche payment in addition to […]

  • ThermoFisher Logo

    Sales Rise at Thermo Fisher by 31% in Q3

    “We’re pleased to extend our long track record of consistently delivering strong adjusted EPS growth,” said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. “We leveraged our solid top-line results and our culture of operational discipline to achieve excellent performance on the bottom line. I’m also pleased to report that the […]

  • Sales at Waters Up 8% in Q3

      Waters Corporation (NYSE:WAT) reported today third quarter 2014 sales of $493 million, an increase of 8% versus sales of $457 million in the third quarter of 2013. In the quarter, the effect of foreign currency translation was neutral to sales growth. On a GAAP basis, earnings per diluted share (EPS) for the third quarter were $1.34 compared to $1.14 for the third […]

  • Agilent to Exit NMR Business

      Agilent Technologies Inc. (NYSE:A) today announced it is exiting its Nuclear Magnetic Resonance business. Agilent entered the NMR business in 2010, with the acquisition of Varian. Since then, the business has not met growth and profitability objectives. Agilent will stop taking new NMR system orders immediately, but the company will continue to meet customer commitments for orders in progress […]

  • Becton Dickinson Acquire GenCell Biosystems

      BD Becton, Dickinson and Company NYSE: BDX, a leading global medical technology company, announced today that it has acquired GenCell Biosystems, a privately-held Irish biotech company that has developed proprietary technologies that address key biological analysis protocols – from library preparation of Next Generation Sequencing NGS to genotyping for agricultural applications. For further details […]

  • Oxford Instruments Appoints New Non-Executive Director

      Oxford Instruments plc, a leading provider of high-technology tools and systems for industry and research, is pleased to announce the appointment of Professor Sir Richard Friend as an Independent Non-Executive Director.  The appointment takes effect from 1 September 2014. Professor Sir Richard Friend is a Fellow of the Royal Society and Fellow of the […]

  • Danaher Corporation Appoints New CEO

      Danaher Corporation (NYSE: DHR) today announced that the Company’s Board of Directors has implemented its previously disclosed succession plan and will appoint Thomas P. Joyce, Jr. as President and Chief Executive Officer and a member of the Board of Directors, effective September 9, 2014. Mr. Joyce’s predecessor, H. Lawrence Culp, Jr., will transition to a senior advisory role. […]

  • Malvern Instruments completes acquisition of MicroCal and announces purchase of Archimedes product from Affinity Biosensors

      Malvern Instruments Ltd (Malvern, UK) has announced that it has completed the acquisition of MicroCal from GE Healthcare Life Sciences and has also purchased the Archimedes particle characterization system from Affinity Biosensors LLC (Santa Barbara, CA). Both of these developments extend Malvern’s portfolio of analytical solutions for the rapidly advancing biopharmaceutical industry. More…

  • Oxford Instruments Announce Prelim Results for FY 2013/14

      Oxford Instruments have announced their preliminary results for the year ending March 31st 2014. Jonathan Flint, Chief Executive described it as another successful result highlighted by a growth in orders, sales and profits compared with the previous year. He added that the integration of Andor Technology is progressing well and the business is performing […]

  • Coherent, Inc. Reports Q1 Results 2014

      Coherent Inc reports Q1 results for 2014 announcing that net sales have increased by 5.7% over the same period in the previous year, reaching $193.6 million. Net income however, dipped 17.6% compared with the same period last year. for the full release, click here; Coherent, Inc. Reports Q1 Results 2014

  • Thermo Fisher Reports Q4 and Full Year 2013 Results

      Thermo Fisher Scientific reports Q4 and full year 2013 results today, January 30 2014. Highlights include revenue growth of 6% for the quarter to $3.47 billion in 2013, versus $3.26 billion in 2012 and revenue for full year 2013 grew 5% to $13.09 billion, versus $12.51 billion a year ago. Also, the acquisition of Life Technologies to add complementary genomics, next-generation sequencing […]